Hello from Lisa at Medscape Global. I'm writing a story for our European physican readers about the issues LGBTQI+ patients have reported having when they seek cancer care. I would like to ask any Europe-based oncology patients who have experienced this issue to share their perspective, to help doctors better understand their patients' needs, and respectfully give them the care they deserve. If you would like to participate, please answer the following brief questions:
1. What is your name, age, country and city of residence, and occupation?
2. What is your email address and phone number?
3. When you were treated for cancer and/or are currently being treated, what would you say was your biggest problem in getting your doctor to undersrand your specific needs?
4. Would you say oncologists understand the experience and perspective of their LGBTQI+ patients in general?
5. How do you think oncologists can better understand and communicate with their LGBTQI+ patients?
6. Could you briefly share an example, either positive or negative, about your treatment experience as an LGBTQI+ patient that you feel was important, in terms of advocating for yourself?
And that's it! Thank you so much for sharing--your generosity will help others!
posted9/25/2025
deadline9/28/2025
processing
published
Recently published by Medscape
Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts
Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care
I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research.
Questions:
What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)?
Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy?
What role do biologic or precision-medicine therapies play in COPD and asthma management today?
What barriers exist in implementing these newer approaches (cost, access, adherence)?
How can primary care providers best incorporate or refer for these innovations?
Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years?
Consent Note:
By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).